Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel.
暂无分享,去创建一个
J. Balser | G. Tomaselli | E. Marbán | D. Johns | H. B. Nuss | N. Kambouris | N. Kambouris
[1] M. Furutani,et al. A de novo missense mutation (R1623Q) of the SCN5A gene in a Japanese girl with sporadic long QT syndrome , 1998, Human mutation.
[2] E. Marbán,et al. Suppression of Neuronal and Cardiac Transient Outward Currents by Viral Gene Transfer of Dominant-Negative Kv4.2 Constructs* , 1997, The Journal of Biological Chemistry.
[3] A. L. Goldin,et al. Interaction between the sodium channel inactivation linker and domain III S4-S5. , 1997, Biophysical journal.
[4] CharlesAntzelevitch,et al. Sodium Channel Block With Mexiletine Is Effective in Reducing Dispersion of Repolarization and Preventing Torsade de Pointes in LQT2 and LQT3 Models of the Long-QT Syndrome , 1997 .
[5] C Antzelevitch,et al. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. , 1997, Circulation.
[6] A. George,et al. Pharmacological targeting of long QT mutant sodium channels. , 1997, The Journal of clinical investigation.
[7] J. Balser,et al. Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels. , 1996, The Journal of clinical investigation.
[8] A. George,et al. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Horn,et al. Role of an S4-S5 linker in sodium channel inactivation probed by mutagenesis and a peptide blocker , 1996, The Journal of general physiology.
[10] R. Kass,et al. Lidocaine block of LQT-3 mutant human Na+ channels. , 1996, Circulation research.
[11] P. Schwartz,et al. Multiple mechanisms of Na+ channel--linked long-QT syndrome. , 1996, Circulation research.
[12] R. Horn,et al. Molecular Basis of Charge Movement in Voltage-Gated Sodium Channels , 1996, Neuron.
[13] G. Tomaselli,et al. Functional association of the beta 1 subunit with human cardiac (hH1) and rat skeletal muscle (mu 1) sodium channel alpha subunits expressed in Xenopus oocytes , 1995, The Journal of general physiology.
[14] S. Priori,et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. , 1995, Human molecular genetics.
[15] A. George,et al. Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.
[16] Arthur J Moss,et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.
[17] D C Ward,et al. Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 3p21. , 1995, Cytogenetics and cell genetics.
[18] Ming Zhou,et al. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation , 1994, Neuron.
[19] M. Weiner,et al. A method for the site-directed mono- and multi-mutagenesis of double-stranded DNA. , 1993, Gene.
[20] A L Goldin,et al. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Leppert,et al. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita , 1992, Neuron.
[22] B. Nilius,et al. Effects of lidocaine on single cardiac sodium channels. , 1987, Journal of molecular and cellular cardiology.